The Turkish Competition Authority re-examines allegations on exclusionary practises in the healthcare sector (Siemens)

Upon the Ankara 7 th Administrative Court’s annulment [1] its 2016 decision [2], the Competition Board (“Board”) re-examined the allegations against Siemens Healthcare Sağlık A.Ş. (“Siemens”) concerning abuse of dominance by way of excluding the competitors, engaging in discriminatory practices, and violating the obligations which had been stipulated in previous Board decisions against Siemens [3]. In conclusion, the Board found that Siemens did not abuse its dominant position in the markets for services and spare parts for the Siemens brand medical diagnostic and imaging devices; thus, did not violate Article 6 of Law No. 4054 on the Protection of Competition (“Law No. 4054”). Background The applicant, Siemed Tıbbi Sistemleri Elektrik Elektronik İletişim Sağlık Hizmetleri Danışmanlık

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • ELIG Gürkaynak Attorneys-at-Law (Istanbul)
  • ELIG Gürkaynak Attorneys-at-Law (Istanbul)
  • ELIG Gürkaynak Attorneys-at-Law (Istanbul)

Citation

Gönenç Gürkaynak, Ceren Özkanlı Samlı, Sinem Ugur, The Turkish Competition Authority re-examines allegations on exclusionary practises in the healthcare sector (Siemens), 19 novembre 2020, e-Competitions November 2020, Art. N° 99879

Visites 76

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues